Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Completed · Phase 3

Conditions studied: Alzheimer Disease

In brief

The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type.

Key facts

Study ID

NCT00041678

Run by

Otsuka Pharmaceutical Development & Commercialization, Inc.

Starts

2000-01-01

Expected to finish

2003-03-01

Last updated by the study team

2013-11-11

Who can join

Age: 55 and older, up to 95. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Institutionalized patients with Alzheimer's Disease

Where it is running

• Local Institution — Rosemead, California, United States
• Local Institution — Miami, Florida, United States
• Local Institution — Nashville, Tennessee, United States
• Local Institution — Bennington, Vermont, United States
• Local Institution — Burlington, Vermont, United States
• Local Institution — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.